- Fund vehicles
- 2
- Launches
- 0
- Form D filings
- 6
- First seen
- 2024-10-11
- Latest filing
- 2026-10-09
- Based in
- California, E9
Sofinnova BioEquities Enhanced: Form D filings
Every fund vehicle filed under the Sofinnova BioEquities Enhanced name since 2024: original launches and D/A raise updates, with offering size, stage, strategy and the people on each filing. Sponsor identity is inferred from the entity name; verify on the filing.
4 filings in the last 730 days · page 1 of 1
| Score | Filed | Issuer | Type | Stage | Offering | Sold | Location | Flags | Source |
|---|---|---|---|---|---|---|---|---|---|
| 37 | 2026-10-09 | Sofinnova BioEquities Enhanced Offshore Fund Ltd. Sofinnova Investments | Hedge fund | Open-ended | Indefinite | $226.3M | Grand Cayman, Cayman Islands | 3(c)(7) — qualified purchasers | EDGAR |
| 27 | 2026-10-09 | Sofinnova BioEquities Enhanced Master Fund, LP | Hedge fund | Open-ended | Indefinite | $87.2M | MENLO PARK, CA | 3(c)(7) — qualified purchasers | EDGAR |
| 37 | 2025-10-10 | Sofinnova BioEquities Enhanced Offshore Fund Ltd. | Hedge fund | Open-ended | Indefinite | $226.3M | Grand Cayman, Cayman Islands | 3(c)(7) — qualified purchasers | EDGAR |
| 27 | 2025-10-10 | Sofinnova BioEquities Enhanced Master Fund, LP | Hedge fund | Open-ended | Indefinite | $41.5M | MENLO PARK, CA | 3(c)(7) — qualified purchasers | EDGAR |
Free weekly sample: five scored private-fund launches every Monday
One week delayed, headline and summary only, no card. It exists so you can judge the scoring before paying.